Archive for February 2019

2018 Enforcement Report for Labelers of Homeopathic Drug Products

Mark Land, AAHP President The most recent year (2018) has been a busy regulatory enforcement period for manufacturers and marketers of homeopathic drug products. Review of the Food and Drug Administration’s (FDA) website reveals enforcement actions against homeopathic products at multiple levels including inspections, warning letters, and recalls. The data readm more…

Read More

New Congress, New Landscape: What it Means for the Homeopathic Industry

By Pete Evich, AAHP Government Relations Shutdown Impacts FDA The 116th Congress commenced on Jan. 3 amidst a turbulent backdrop of a partial federal government shutdown. On Jan. 25, after a record-breaking 35-day shutdown, President Trump agreed to sign legislation to fund the impacted federal government agencies until Feb. 15. readm more…

Read More

Outlook 2019: A Letter from the Board

By AAHP Board of Directors 2019 presents a unique crossroad to the homeopathic industry. As consumer demand for our products rises across North America, so does industry growth—and it is poised to continue growing. With this increased visibility comes increased scrutiny from regulatory bodies and potentially unfriendly consumer groups. While readm more…

Read More

Accelerating into the New Year

By Mark Land, AAHP President   As the homeopathic industry continues to grow, AAHP recognizes the need for constant improvement. This year, building on the momentum we gained in 2018, we plan to accelerate our efforts in the areas of advocacy, education, and outreach. All of our efforts aim to readm more…

Read More